CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- UPLOAD Other SEC-generated Letter
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Agreement ended · Executive or director change
- S-4 Deal Registration Statement - Business Combination
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
- 10-K Report Annual Report
- 8-K Event Executive or director change
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure
- 8-K Event Delisting notice
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
Page 8 of 34 · 678 filings